The Patent Finder

Onclave Therapeutics

Also on record
Records under this name other than patents Onclave Therapeutics holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Onclave Therapeutics

PatentTitleStatus Expires Confidence
US 8,268,973Anti-amyloid antibodies
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,404,815Chimeric, Humanized, or Human Antibody 2A4
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,636,981Detection of Amyloid Deposits Using Anti-Amyloid Antibodies
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,928,203Chimeric, Humanized, or Human Antibody 2A4
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,089,529Antibody formulations and methods
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,884,020Antibody formulations and methods for treating AL amyloidosis
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,517,830Antibody formulations and methods
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,791,243Treatment and Prophylaxis of Amyloidosis
Formerly held
Lapsed on the fee record
Ended Jul 29, 2026 · High confidence
Lapsed on the fee recordEnded Jul 29, 2026High confidence
US 7,977,316Prevention and Treatment of Amyloidogenic Diseases
Lapsed on the fee record
Ended Jul 12, 2019 · Medium confidence
Lapsed on the fee recordEnded Jul 12, 2019Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited